Objective Fungal infections are becoming a major medical problem. Life-threatening Candida, Coccidiodes, Cryptococcus, Histoplasma, and Aspergillus infections are on the increase. The most common fungal pathogen of humans, Candida albicans, causes superficial infections of mucosal epithelia, but also deep-seated infections, particular in immunocompromised patients, which are often fatal. The increasing use of immunosuppressive therapy and the spread of AIDS has led to a steep increase in the incidence of fungal infections. Few effective and safe antifungal drugs are available and the frequency of drug-resistant fungal is increasing. Hence, new and effective antifungal drugs must be developed. The identification of new antifungal targets depends upon strong fundamental research programmes, which are the topics of this Conference Series. Fields of science natural sciencesbiological sciencesmicrobiologymycologymedical and health scienceshealth sciencesinfectious diseasesRNA virusesHIV Programme(s) FP5-HUMAN POTENTIAL - Programme for research, technological development and demonstration on "Improving the human research potential and the socio-economic knowledge base" (1998-2002) Topic(s) 1.4.1.-3.1. - High-level Scientific Conferences Call for proposal Data not available Funding Scheme SC - High Level Scientific Conference Coordinator EUROPEAN SCIENCE FOUNDATION EU contribution No data Address Quai Lezay-MarnTsia 1 67080 Strasbourg France See on map Total cost No data